ADIA to Invest USD 200 Million in Meril

.

Vapi, India– [20 July 2025] – A wholly-owned subsidiary of the Abu Dhabi Investment Authority ("ADIA") has entered into definitive agreements to invest USD 200 million for an ~3% equity stake in Micro Life Sciences Private Limited ("Meril"), a leading Indian medical devices firm. The investment places an enterprise value of USD 6.6 billion on Meril. The transaction is pending clearance by India's Competition Commission of India (CCI). Once this investment is made, Meril will have two globally respected investors, ADIA and Warburg Pincus, backing it. Founded by the Bilakhia Group, Meril is a global MedTech leader that has a strong passion for clinically superior products across specialties — Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics.

Headquartered in Vapi, India, Meril has state-of-the-art, globally certified and vertically integrated manufacturing and R&D facilities, spanning a 100 acre green MedTech campus. Meril employs more than 13,000 people, 35+ international subsidiaries, and touches healthcare systems in 150+ nations. Meril aims to become the world's largest MedTech business, powered 100% by green energy, reiterating its commitment to sustainable innovation.

With a strong in-house global R&D setup and a portfolio of 200+ technologies, Meril remains a global leader in clinical research and education. Its pioneering advancements such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System establish Meril's dedication to innovation tomorrow. With 12+ training academies worldwide, Meril educates over 10,000 medical professionals annually.

..

Sanjeev Bhatt, Executive Vice President – Strategy, Meril added: "This investment by ADIA reiterates confidence in the long term vision and global aspirations of Meril. This investment will enable us to grow faster, build world-class capability, and increase our R&D and clinical research capabilities as we work towards improving the quality of human life through innovative healthcare solutions."

About Meril

Meril is a global medical technology company with its headquarters in Vapi, India. Committed to innovation, Meril develops clinically relevant products with the aim of enhancing patient outcomes in cardiovascular, orthopaedic, diagnostic, Endo Surgery and robotic surgery space. The Bilakhia Group established the company with a focus on sustainability, quality, and global presence.

For more information:  https://www.merillife.com

About Abu Dhabi Investment Authority (ADIA)

Established in 1976, the Abu Dhabi Investment Authority ("ADIA") is an internationally diversified investment fund investing funds on behalf of the Government of Abu Dhabi in a value creation strategy with a long-term focus. For more: https://www.adia.ae

Media contact : media@merillife.com

Moneycontrol journalists were not involved in the creation of the article.